[
    [
        {
            "time": "",
            "original_text": "医药行业周报：建议关注新冠疫苗研发动态及三季报披露情况",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "研发动态",
                    "三季报",
                    "医药行业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业周报：建议关注新冠疫苗研发动态及三季报披露情况",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【行情】疫苗板块再度走强，博晖创新大涨10%，万方发展、沃森生物、万泰生物、康华生物等跟涨",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "博晖创新",
                    "万方发展",
                    "沃森生物",
                    "万泰生物",
                    "康华生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【行情】疫苗板块再度走强，博晖创新大涨10%，万方发展、沃森生物、万泰生物、康华生物等跟涨",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "沃森生物参股公司于香港联交所挂牌上市，公司拥有其8.60%权益",
            "features": {
                "keywords": [
                    "沃森生物",
                    "参股公司",
                    "香港联交所",
                    "挂牌上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物参股公司于香港联交所挂牌上市，公司拥有其8.60%权益",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]